About Us
InSymbiosis is a contract research organization (CRO) that leverages a unique virtual CRO model or vCRO. Our model, which we also call our “drug development engine” enables us to provide highly customized drug development services to the global biopharma industry. Founded in 2005, InSymbiosis has a proven track record of supporting both small biotech and big pharma companies. InSymbiosis provide a “one-stop-shop” model where we offer enabling and integrated services for discovery, bioanalysis/analysis, drug safety assessment, chemistry, manufacture and control and clinical development. Our speciality is transitioning drug development candidates from preclinical to human clinical proof of concept across most therapeutic areas. What makes us further unique is our ability to provide our clients with dramatic cost saving solutions through our leveraging of a variety of novel cost reduction strategies. At the same time, our attention to scientific integrity, quality and regulatory compliance ensures that the programs outsourced to InSymbiosis withstand the rigours of regulatory authority scrutiny and investor due diligence. The result, InSymbiosis delivers a truly unique, game changing outsourcing solution to the biopharma industry.